Associate Professor of Pharmaceutics
University of Sadat City, Egypt
I obtained my BSc degree in Pharmaceutical Sciences and MSc in Pharmaceutics from Ain Shams University, Egypt, in 2006 and 2011. During my MSc studies, I designed different lipid nanocarriers for efficient brain targeting of clonazepam as an anticonvulsant drug. Afterward, I pursued PhD in Pharmaceutics at the Faculty of Pharmacy, Ain Shams University. The project focused on developing a novel injectable nanocomposite containing cisplatin to improve efficiency against colorectal cancer with reduced adverse effects. Currently, I’m an Associate Professor of Pharmaceutics at the University of Sadat City, Egypt. The main arena of my research has been the development of novel nanocarriers with a special focus on cancer targeting.
In 2018, I was granted the Newton-Musharafa grant funded by the British Council for my postdoc studies and joined Professor Khuloud Al-Jamal’s team at King’s College London (KCL), to develop different novel lipid nanocarriers for efficient delivery of siRNA to cancer. In 2019, I was awarded the Schlumberger Foundation- Faculty for the Future fellowship award and re-joined KCL to work on the development of lipid nanocarriers for efficient RNAi-based cancer immunotherapy. Meanwhile, I had the following research projects:
• Schlumberger Foundation-Faculty for the Future fellowship renewal award 2022 in KCL.
• Potential protective effect of verapamil-loaded quantum dots against lipopolysaccharide-induced learning and memory impairment; in-vitro and in-vivo Alzheimer-like models, funded by STDF, Egypt, grant number 45960.
• Nanofabrication of smart biodegradable 3D electrospun/ Bio-printed doxorubicin loaded implant as a sustained-release dosage form for breast cancer immunotherapy, funded by STDF, Egypt, grant number 45769.
• Utilization of polymeric micelles as a lucrative platform for efficient brain deposition of olanzapine as an anti-schizophrenic drug via intranasal delivery, funded by TAIF University, Kingdom Saudi Arabia.
• Drug repurposing approach utilizing virtual screening for targeting COVID-19, funded by the University of Sadat City.